Development of glutathione S-transferase-P-negative foci accompanying nuclear factor-erythroid 2-related factor 2 expression during early stage of rat hepatocarcinogenesis

Cancer Science

Volumn 99, Issue 3, 2008, Pages 497-501

  Fan, Yang ^a   Shimizu, Takeshi ^a   Yamada, Toshiyuki ^a   Nanishima, Naoki ^a,b   Akita, Miki ^a   Asano, Jumpei ^a   Tsuchida, Shigeki ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; GLUTATHIONE TRANSFERASE; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SIZE; CANCER STAGING; CELL VACUOLE; CONTROLLED STUDY; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER INJURY; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 38949173151     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00703.x     Document Type: Article

References (32)

1. Tsuchida S, Sato K. Glutathione transferases and cancer. Crit Rev Biochem Mol Biol 1992; 27: 337-84.
2. Satoh K, Kitahara A, Soma Y, Inaba Y, Hatayama I, Sato K. Purification, induction, and distribution of placental glutathione transferase: A new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc Natl Acad Sci USA 1985; 82: 3964-8.
3. Adler V, Yin Z, Fuchs SY et al. Regulation of JNK signaling by GSTp. EMBO J 1999; 18: 1321-34.
4. 2-induced cell death via coordinated regulation of stress kinases. Cancer Res 2000; 60: 4053-7.
5. Ikeda H, Nishi S, Sakai M. Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepatocarcinogenesis. Biochem J 2004; 380: 515-21.
6. Solt D, Farber E. New principle for the analysis of chemical carcinogenesis. Nature 1976; 263: 701-3.
7. Farber E, Parker S, Gruenstein M. The resistance of putative premalignant liver cell populations, hyperplastic nodules, to the acute cytotoxic effects of some hepatocarcinogens. Cancer Res 1976; 36: 3879-87.
8. Satoh K, Hatayama I, Tateoka N et al. Transient induction of single GST-P positive hepatocytes by DEN. Carcinogenesis 1989; 10: 2107-11.
9. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl Acids Res 1983; 11: 1475-89.
10. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
11. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4.
12. Sato K. Glutathione transferases as markers of preneoplasia and neoplasia. Adv Cancer Res 1989; 52: 205-55.
13. Imagawa M, Osada S, Okuda A, Muramatsu M. Silencer binding proteins function on multiple cis-elements in the glutathione transferase P gene. Nucleic Acids Res 1991; 19: 5-10.
14. Morimura S, Suzuki T, Hochi S et al. Trans-activation of glutathione transferase P gene during chemical hepatocarcinogenesis of the rat. Proc Natl Acad Sci USA 1993; 90: 2065-8.
15. Sakai M, Okuda A, Muramatsu M. Multiple regulatory elements and phorbol 12-O-tetradecanoate 13-acetate responsiveness of the rat placental glutathione transferase gene. Proc Natl Acad Sci USA 1988; 85: 9456-60.
16. Suzuki T, Imagawa M, Hirabayashi M et al. Identification of an enhancer responsible for tumor marker gene expression by means of transgenic rats. Cancer Res 1995; 55: 2651-5.
17. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 2002; 62: 5196-203.
18. Ikeda H, Omoteyama K, Yoshida K, Nishi S, Sakai M. CCAAT enhancer-binding protein alpha suppresses the rat placental glutathione S-transferase gene in normal liver. J Biol Chem 2006; 281: 6734-41.
19. Ohta K, Ohigashi M, Naganawa A et al. Histone acetyltransferase MOZ acts as a co-activator of Nrf2-MafK and induces tumour marker gene expression during hepatocarcinogenesis. Biochem J 2007; 402: 559-66.
20. Satoh K, Itoh K, Yamamoto M et al. Nrf2 transactivator-independent GSTP1-1 expression in 'GSTP1-1 positive'single cells inducible in female mouse liver by DEN: A preneoplastic character of possible initiated cells. Carcinogenesis 2002; 23: 457-62.
21. Elsby R, Kitteringham NR, Goldring CE et al. Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi. J Biol Chem 2003; 278: 22243-9.
22. Ip YT, Davis RJ. Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr Opin Cell Biol 1998; 10: 205-19.
23. Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A, Green DR. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol Cell 1998; 1: 543-51.
24. Tournier C, Hess P, Yang DD et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 2000; 288: 870-4.
25. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-31.
26. Yang DD, Kuan CY, Whitmarsh AJ et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 1997; 389: 865-70.
27. Iyoda K, Sasaki Y, Horimoto M et al. Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma. Cancer 2003; 97: 3017-26.
28. 2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 2001; 411: 102-7.
29. Gate L, Majumdar RS, Lunk A, Tew KD. Increased myeloproliferation in glutathione S-transferase pi-deficient mice is associated with a deregulation of JNK and Janus kinase/STAT pathways. J Biol Chem 2004; 279: 8608-16.
30. Denda A, Kitayama W, Konishi Y et al. Genetic properties for the suppression of development of putative preneoplastic glutathione S-transferase placental form-positive foci in the liver of carcinogen-resistant DRH strain rats. Cancer Lett 1999; 140: 59-67.
31. Higashi K, Hiai H, Higashi T, Muramatsu M. Regulatory mechanism of glutathione S-transferase P-form during chemical hepatocarcinogenesis: old wine in a new bottle. Cancer Lett 2004; 209: 155-63.
32. Yan Y, Zeng ZZ, Higashi S et al. Resistance of DRH strain rats to chemical carcinogenesis of liver: Genetic analysis of later progression stage. Carcinogenesis 2002; 23: 189-96.